
© 2025 Edison Investment Research
Realtime | Geld | Brief | Zeit |
---|---|---|---|
42,300 | 42,900 | 16.02. | |
0,000 | 0,000 | 28.03.23 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
09.02. | Basilea Pharmaceutica Aktie: Hoffnungsträger des Marktes! | Die Basilea Pharmaceutica zeigt sich derzeit in robuster Verfassung an der Börse. Mit einer Marktkapitalisierung von 560 Millionen Euro und einem aktuellen Kurs von 42,75 Euro verzeichnet das Schweizer... ► Artikel lesen | |
06.02. | Basilea Pharmaceutica - Encouraging start to the year for Cresemba | Basilea Pharmaceutica has continued its strong momentum into 2025, announcing the receipt of a CHF1.2m milestone payment for Cresemba for the strategically important Japanese market. This marks the... ► Artikel lesen | |
05.02. | Basilea Pharmaceutica (SIX: BSLN) records first commercial milestone payment from Japan | Basilea Pharmaceutica has announced the receipt of its first commercial milestone payment of CHF1.2m from partner Asahi Kasei Pharma (AKP) for reaching an undisclosed sales threshold in Japan for its... ► Artikel lesen | |
05.02. | Basilea erhält Meilenstein-Zahlung von japanischem Partner Asahi Kasei | ||
05.02. | Basilea Pharmaceutica AG: Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea | Allschwil, Switzerland, February 05, 2025
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial... ► Artikel lesen |